Hye Sang Park (Hye S Park, Hye Park)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Rheumatoid Arthritis

Radical Prostatectomy

Cross Sectional

Disease Activity

Top Venues

Journal of clinical medicine

Medicina (Kaunas, Lithuania)

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Cristina Martinez-Molina, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina (Kaunas, Lithuania) 60 (3) (2024)
Cristina Martinez-Molina, Anna Feliu Ribera, Hye Sang Park, Ana Juanes, Cesar Diaz-Torné, Silvia Vidal, Hèctor Corominas
Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients? Journal of clinical medicine 13 (8) (2024)
Cristina Martinez-Molina, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina (Kaunas, Lithuania) 60 (3) (2024)
Cristina Martinez-Molina, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina (Kaunas, Lithuania) 60 (3) (2024)
Helena Codes-Méndez, Luis Sainz, Hye Sang Park, Hèctor Corominas, Cesar Diaz-Torné
Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort. RMD open 10 (2) (2024)
Helena Codes-Méndez, Luis Sainz, Hye Sang Park, Hèctor Corominas, Cesar Diaz-Torné
Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort. RMD open 10 (2) (2024)
Cristina Martinez-Molina, Ignasi Gich, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study. Scientific reports 14 (1) (2024)
Helena Codes-Méndez, Luis Sainz, Hye Sang Park, Hèctor Corominas, Cesar Diaz-Torné
Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort. RMD open 10 (2) (2024)
Helena Codes-Méndez, Luis Sainz, Hye Sang Park, Hèctor Corominas, Cesar Diaz-Torné
Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort. RMD open 10 (2) (2024)
Cristina Martinez-Molina, Anna Feliu Ribera, Hye Sang Park, Ana Juanes, Cesar Diaz-Torné, Silvia Vidal, Hèctor Corominas
Are There Sex-Related Differences in the Effectiveness of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients? Journal of clinical medicine 13 (8) (2024)
Cristina Martinez-Molina, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis. Medicina (Kaunas, Lithuania) 60 (3) (2024)
Cristina Martinez-Molina, Ignasi Gich, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study. Scientific reports 14 (1) (2024)
Cristina Martinez-Molina, Ignasi Gich, Cesar Diaz-Torné, Hye Sang Park, Anna Feliu Ribera, Silvia Vidal, Hèctor Corominas
Patient-related factors influencing the effectiveness and safety of Janus Kinase inhibitors in rheumatoid arthritis: a real-world study. Scientific reports 14 (1) (2024)
Rubén Queiro, Daniel Seoane-Mato, Ana Laiz, Eva Galindez Agirregoikoa, Carlos Montilla, Hye Sang Park, Jose A Pinto Tasende, Juan J Bethencourt Baute, Beatriz Joven Ibáñez, Elide Toniolo, Julio Ramírez, Nuria Montero, Cristina Pruenza García-Hinojosa, Ana Serrano García, null On Behalf Of The Proyecto Reapser Study
Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis-Multivariable Prediction Model Based on Machine Learning. Journal of clinical medicine 12 (3) (2023)
Rubén Queiro, Daniel Seoane-Mato, Ana Laiz, Eva Galindez Agirregoikoa, Carlos Montilla, Hye Sang Park, Jose A Pinto Tasende, Juan J Bethencourt Baute, Beatriz Joven Ibáñez, Elide Toniolo, Julio Ramírez, Nuria Montero, Cristina Pruenza García-Hinojosa, Ana Serrano García, null On Behalf Of The Proyecto Reapser Study
Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis-Multivariable Prediction Model Based on Machine Learning. Journal of clinical medicine 12 (3) (2023)
Rubén Queiro, Daniel Seoane-Mato, Ana Laiz, Eva Galindez Agirregoikoa, Carlos Montilla, Hye Sang Park, Jose A Pinto Tasende, Juan J Bethencourt Baute, Beatriz Joven Ibáñez, Elide Toniolo, Julio Ramírez, Nuria Montero, Cristina Pruenza García-Hinojosa, Ana Serrano García, null On Behalf Of The Proyecto Reapser Study
Moderate-High Disease Activity in Patients with Recent-Onset Psoriatic Arthritis-Multivariable Prediction Model Based on Machine Learning. Journal of clinical medicine 12 (3) (2023)
Luis Sainz, Pau Riera, Patricia Moya, Sara Bernal, Jordi Casademont, Cesar Díaz-Torné, Ana Milena Millán, Hye Sang Park, Adriana Lasa, Hèctor Corominas
Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis. Pharmaceutics 14 (9) (2022)
Berta Magallares, David Lobo-Prat, Ivan Castellvi, Patricia Moya, Ignasi Gich, Laura Martinez-Martinez, Hye Sang Park, Ana Milena Millán, Ana Laiz, Cesar Diaz-Torné, Susana Fernandez, Hèctor Corominas
Assessment of EULAR/ACR-2019, SLICC-2012 and ACR-1997 Classification Criteria in SLE with Longstanding Disease. Journal of clinical medicine 10 (11) (2021)